Glycosylphosphatidylinositol-specific phospholipase D immunoreactivity is present in islet amyloid in type 2 diabetes

Journal of Pathology

Volumn 203, Issue 4, 2004, Pages 961-967

  Larson, D M ^a   Kennedy, M A ^b   Bowen, R F ^a   Verchere, C B ^b   Deeg, M A ^a,c  

^a INDIANA UNIVERSITY   (United States)

^b CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

^c Department of Endocrinology IIIE ^*  (United States)

Author keywords

cell; Amyloid; Glycosylphosphatidylinositol; GPI PLD; Heparan sulphate proteoglycan; Islets; Type 2 diabetes

Indexed keywords

AMYLIN; AMYLOID; APOLIPOPROTEIN A1; GLYCOSYLPHOSPHATIDYLINOSITOL; HEPARAN SULFATE; HEPARIN; INSULIN; PHOSPHOLIPASE D; PROTEOHEPARAN SULFATE;

ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; IN VITRO STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS;

AMYLOID; DIABETES MELLITUS, TYPE 2; HEPARAN SULFATE PROTEOGLYCANS; HUMANS; ISLETS OF LANGERHANS; MICROSCOPY, CONFOCAL; PHOSPHOLIPASE D;

EID: 4143103752     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1600     Document Type: Article

References (49)

1. Kahn SE, Andrikopoulos S, Verchere CB. Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes. Diabetes 1999; 48: 241-253.
2. Lorenzo A, Razzaboni B, Weir GC, Yankner BA. Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus. Nature 1994; 368: 756-760.
3. Charge SB, Esiri MM, Bethune CA, Hansen BC, Clark A. Apolipoprotein E is associated with islet amyloid and other amyloidoses: implications for Alzheimer's disease. J Pathol 1996; 179: 443-447.
4. Young ID, Ailles L, Narindrasorasak S, Tan R, Kisilevsky R. Localization of the basement membrane heparan sulfate proteoglycan in islet amyloid deposits in type II diabetes mellitus. Arch Pathol Lab Med 1992; 116: 951-954.
5. Westermark P. The pathogenesis of amyloidosis: understanding general principles. Am J Pathol 1998; 152: 1125-1127.
6. Wisniewski T, Golabek AA, Kida E, Wisniewski KE, Frangione B. Conformational mimicry in Alzheimer's disease. Role of apolipoproteins in amyloidogenesis. Am J Pathol 1995; 147: 238-244.
7. Kida E, Choi-Miura NH, Wisniewski KE. Deposition of apolipoproteins E and J in senile plaques is topographically determined in both Alzheimer's disease and Down's syndrome brain. Brain Res 1995; 685: 211-216.
8. Harr SD, Uint L, Hollister R, Hyman BT, Mendez AJ. Brain expression of apolipoproteins E, J, and A-I in Alzheimer's disease. J Neurochem 1996; 66: 2429-2435.
9. Choi-Miura NH, Ihara Y, Fukuchi K, et al. SP-40,40 is a constituent of Alzheimer's amyloid. Acta Neuropathol (Berlin) 1992; 83: 260-264.
10. Thomas EA, Sautkulis LN, Criado JR, Games D, Sutcliffe JG. Apolipoprotein D mRNA expression is elevated in PDAPP transgenic mice. J Neurochem 2001; 79: 1059-1064.
11. Hoener MC, Brodbeck U. Phosphatidylinositol-glycan-specific phospholipase D is an amphiphilic glycoprotein that in serum is associated with high-density lipoproteins. Eur J Biochem 1992; 206: 747-757.
12. Deeg MA, Bierman EL, Cheung MC. GPI-specific phospholipase D associates with an apoA-I- and apoA-IV-containing complex. J Lipid Res 2001; 42: 442-451.
13. Low MG. Structure and function of GPI-specific phospholipases. In PNH and the GPI-Linked Proteins, Young NG, Moss J (eds). Academic Press: San Diego, CA, 2000; 239-268.
14. LeBoeuf RC, Caldwell M, Guo Y, et al. Mouse glycosylphosphatidylinositol-specific phospholipase D (Gpld1) characterization. Mam Gen 1998; 9: 710-714.
15. Stadelmann B, Zurbiggen A, Brodbeck U. Distribution of glycosylphosphatidylinositol-specific phospholipase D mRNA in bovine tissue sections. Cell Tissue Res 1993; 274: 547-552.
16. Metz CN, Zhang Y, Guo Y, et al. Production of the glycosylphosphatidylinositol-specific phospholipase D by the islets of Langerhans. J Biol Chem 1991; 266: 17 733-17 736.
17. Deeg MA, Verchere CB. Regulation of GPI-specific phospholipase D secretion from βTC3 cells. Endocrinology 1997; 138: 819-826.
18. Bowen RF, Raikwar NS, Olson LK, Deeg MA. Glucose and insulin regulate GPI-specific phospholipase D expression in islet β cells. Metabolism 2001; 50: 1489-1492.
19. Maguire GA, Gossner A. Glycosyl phosphatidyl mositol phospholipase D activity in human serum. Annu Clin Biochem 1995; 32: 74-78.
20. Rhode H, Lopatta E, Schulze M, et al. Glycosylphosphatidylinositol-specific phospholipase D in blood serum: is the liver the only source of the enzyme? Clin Chim Acta 1999; 281: 127-145.
21. Deeg MA, Bowen RF, Williams MD, Olson LK, Kirk EA, LeBoeuf RC. Increased expression of GPI-specific phospholipase D in mouse models of type 1 diabetes. Am J Physiol Endocrinol Metab 2001; 281: E147-E154.
22. Rhode H, Schulze M, Cumme GA, et al. Glycosylphosphatidylinositol-specific phospholipase D of human serum - activity modulation by naturally occurring amphiphiles. Biol Chem 2000; 381: 471-485.
23. Deeg MA, Bowen RF. Midportion antibodies stimulate glycosylphosphatidylinositol-specific phospholipase D activity. Arch Biochem Biophys 1999; 370: 278-284.
24. Olin KL, Potter-Perigo S, Barrett PH, Wight TN, Chait A. Lipoprotein lipase enhances the binding of native and oxidized low density lipoproteins to versican and biglycan synthesized by cultured arterial smooth muscle cells. J Biol Chem 1999; 274: 34 629-34 636.
25. Verchere CB, D'Alessio DA, Palmiter RD, et al. Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide. Proc Natl Acad Sci U S A 1996; 93: 3492-3496.
26. Naiki H, Higuchi K, Hosokawa M, Takeda T. Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1. Anal Biochem 1989; 177: 244-249.
27. Kudva YC, Mueske C, Butler PC, Eberhardt NL. A novel assay in vitro of human islet amyloid polypeptide amyloidogenesis and effects of insulin secretory vesicle peptides on amyloid formation. Biochem J 1998; 331: 809-813.
28. Higham CE, Jaikaran ET, Fraser PE, Gross M, Clark A. Preparation of synthetic human islet amyloid polypeptide (IAPP) in a stable conformation to enable study of conversion to amyloid-like fibrils. FEBS Lett 2000; 470: 55-60.
29. Hoener MC, Golli R, Brodbeck U. Glycosyl-phosphatidylinositol-specific phospholipase D: interaction with and stimulation by apolipoprotein A-I. FEBS Lett 1993; 327: 203-206.
30. Kurtz TA, Fineberg NS, Considine RV, Deeg MA. Insulin resistance is associated with increased serum levels of glycosylphosphatidylinositol-specific phospholipase D. Metabolism 2004; 53: 138-139.
31. Deeg MA, Bowen RF. Phosphorylation decreases trypsin activation and apolipoprotein al binding to glycosylphosphatidylinositol-specific phospholipase D. Biochem Cell Biol 2002; 80: 253-260.
32. Vidal J, Bruce Verchere C, Andrikopoulos S, et al. The effect of apolipoprotein E deficiency on islet amyloid deposition in human islet amyloid polypeptide transgenic mice. Diabetologia 2003; 46: 71-79.
33. Hartman RE, Laurer H, Longhi L, et al. Apolipoprotein E4 influences amyloid deposition but not cell loss after traumatic brain injury in a mouse model of Alzheimer's disease. J Neurosci 2002; 22: 10 083-10 087.
34. Esler WP, Marshall JR, Stimson ER, et al. Apolipoprotein E affects amyloid formation but not amyloid growth in vitro: mechanistic implications for apoE4 enhanced amyloid burden and risk for Alzheimer's disease. Amyloid 2002; 9: 1-12.
35. Deeg MA, Davitz MA. Structure and function of the glycosylphosphatidylinositol-specific phospholipase D. In Signal-Activated Phospholipases, Liscovitch M (ed). RG Landes Company: Austin, 1994; 125-138.
36. Springer TA. Folding of the N-terminal, ligand-binding region of integrin alpha-subunits into a beta-propeller domain. Proc Natl Acad Sci USA 1997; 94: 65-72.
37. Snow AD, Willmer J, Kisilevsky R. Sulfated glycosaminoglycans: a common constituent of all amyloids? Lab Invest 1987; 56: 120-123.
38. Norling B, Westermark GT, Westermark P. Immunohistochemical identification of heparan sulphate proteoglycan in secondary systemic amyloidosis. Clin Exp Immunol 1988; 73: 333-337.
39. Cardin AD, Weintraub HJ. Molecular modeling of protein-glycosaminoglycan interactions. Arteriosclerosis 1989; 9: 21-32.
40. Lookene A, Chevreuil O, Ostergaard P, Olivecrona G. Interaction of lipoprotein lipase with heparin fragments and with heparan sulfate: stoichiometry, stabilization, and kinetics. Biochemistry 1996; 35: 12 155-12 163.
41. Mulloy B, Forster MJ. Conformation and dynamics of heparin and heparan sulfate. Glycobiology 2000; 10: 1147-1156.
42. Kreuger J, Salmivirta M, Sturiale L, Gimenez-Gallego G, Lindahl U. Sequence analysis of heparan sulfate epitopes with graded affinities for fibroblast growth factors 1 and 2. J Biol Chem 2001; 276: 30 744-30 752.
43. Bohrmann B, Tjernberg L, Kuner P, et al. Endogenous proteins controlling amyloid beta-peptide polymerization. Possible implications for beta-amyloid formation in the central nervous system and in peripheral tissues. J Biol Chem 1999; 274: 15 990-15 995.
44. Westermark P, Li ZC, Westermark GT, Leckstrom A, Steiner DF. Effects of beta cell granule components on human islet amyloid polypeptide fibril formation. FEBS Lett 1996; 379: 203-206.
45. Janciauskiene, S, Eriksson S, Carlemalm E, Ahren B. B cell granule peptides affect human islet amyloid polypeptide (IAPP) fibril formation in vitro. Biochem Biophys Res Commun 1997; 236: 580-585.
46. Komano H, Seeger M, Gandy S, Wang GT, Krafft GA, Fuller RS. Involvement of cell surface glycosyl-phosphatidylinositol-linked aspartyl proteases in alpha-secretase-type cleavage and ectodomain solubilization of human Alzheimer beta-amyloid precursor protein in yeast. J Biol Chem 1998; 273: 31 648 -31 651.
47. Sambamurti K, Sevlever D, Koothan T, et al. Glycosylphosphatidylinositol-anchored proteins play an important role in the biogenesis of the Alzheimer's amyloid beta-protein. J Biol Chem 1999; 274: 26 810-26 814.
48. Brunner G, Metz CN, Nguyen H, et al. An endogenous glycosylphosphatidylinositol-specific phospholipase D releases basic fibroblast growth factor-heparan sulfate proteoglycan complexes from human bone marrow cultures. Blood 1994; 83: 2115-2125.
49. Metz CN, Brunner G, Choi-Muira NH, et al. Release of GPI-anchored membrane proteins by a cell-associated GPI-specific phospholipase D. EMBO J 1994; 13: 1741-1751.